Approvals· August 27, 2026 · 18 min read
Tivicay PD's Neonatal Expansion: Term, 2 kg Floor; Tablets Do Not Substitute
By Ran Chen#FDA Approval#HIV#Infectious Disease
Topic
Infectious Disease
Vaccines, antivirals, HIV, PrEP, antimicrobial access, payer policy, and public-health commercialization.
Approvals· August 5, 2026 · 16 min read
mFlusiva mRNA flu vaccine meets frozen ACIP: 2026-27 FDA decision and access
By Ran Chen#Infectious Disease#FDA Approval#PDUFA Date
Pipeline· July 31, 2026 · 20 min read
mRNA Vaccines Pipeline by the Numbers (2026): 459 Clinical Trials
By Ran Chen#Clinical Trials#RNA Therapy#FDA Approval
Policy· July 26, 2026 · 18 min read
AMR Pipeline by the Numbers: FDA Antibacterials and the PASTEUR Act
Evidence· July 12, 2026 · 17 min read
Non-HIV Antivirals in FAERS: 508,024 Adverse-Event Reports by the Numbers
Pricing & Access· July 11, 2026 · 16 min read
GSK Portfolio Dossier: ViiV HIV, Nucala Runway, and Oncology Rebuild
By Ran Chen#HIV#Respiratory#Infectious Disease
Evidence· July 6, 2026 · 16 min read
Azole Antifungal Adverse Events: FAERS By the Numbers
Approvals· June 30, 2026 · 18 min read
Utebzi (tebipenem pivoxil) FDA Approval: Stewardship & Launch Access
Pricing & Access· June 21, 2026 · 6 min read
Bicillin L-A Shortage: FDA's Lentocilin Importation and Billing Guidance
Evidence· June 17, 2026 · 14 min read